Aigen Investment Management LP bought a new position in agilon health, inc. (NYSE:AGL – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 20,016 shares of the company’s stock, valued at approximately $79,000.
A number of other hedge funds and other institutional investors have also modified their holdings of AGL. J.Safra Asset Management Corp increased its stake in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after acquiring an additional 3,625 shares during the last quarter. City State Bank acquired a new stake in shares of agilon health in the 3rd quarter worth $52,000. CWM LLC increased its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health in the 2nd quarter worth $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in shares of agilon health in the 1st quarter worth $65,000.
agilon health Stock Performance
Shares of AGL opened at $1.58 on Monday. The stock has a 50-day simple moving average of $3.05 and a 200-day simple moving average of $4.85. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $650.99 million, a PE ratio of -1.68 and a beta of 0.60. agilon health, inc. has a 1 year low of $1.58 and a 1 year high of $13.76.
Insider Activity
In other agilon health news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 3.20% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the company. Stifel Nicolaus lowered their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft lowered their price target on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Benchmark reiterated a “buy” rating and set a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Finally, TD Cowen lowered their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, agilon health currently has a consensus rating of “Hold” and an average price target of $6.38.
Check Out Our Latest Research Report on AGL
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- Investing in Travel Stocks Benefits
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What is a Stock Market Index and How Do You Use Them?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Energy and Oil Stocks Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.